News | February 25, 2026
Lupin launches generic Brivaracetam oral solution in US to treat epilepsy
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
Efinaconazole Topical Solution is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Sugemalimab, developed using CStone’s OmniRat transgenic platform, is a fully human IgG4 monoclonal antibody designed to minimize immunogenicity and toxicity
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
Under the deal, Quiver will receive an undisclosed advance payment and research support
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The study will test the company’s lead product, ZI-MA4-1, in patients with advanced solid cancers
The study is a collaboration between AIM, AstraZeneca, and Erasmus Medical Center in the Netherlands
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
Subscribe To Our Newsletter & Stay Updated
